CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 14, 2024 · earnings

GLUE earnings: a negative outcome, -8.4%

On March 14, 2024, Monte Rosa Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.4% in the window around the event. It had already run +46.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$6.65
1d before
$6.09
Event day
$6.41
1d after
$6.92
5d after

Pre-catalyst setup

+46.0%
30-day run-up
11678%
30-day volatility
1.0×
volume spike